Patents by Inventor Michel Xilinas

Michel Xilinas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of phanquinone for the treatment of Alzheimer's disease
    Patent number: 7629354
    Abstract: The use of phanquinone for the manufacture of a pharmaceutical composition for the prevention or the treatment of Alzheimer's disease is disclosed. Also methods of treatment or prevention of Alzheimer's disease are disclosed.
    Type: Grant
    Filed: November 18, 2003
    Date of Patent: December 8, 2009
    Assignee: Prana Biotechnology Limited
    Inventors: Michel Xilinas, Panayotis Nikolas Gerolymatos
  • Method for Treating Cancer, Coronary, Inflammatory and Macular Disease, Combining the Modulation of Zinc-and/or Copper Dependent Proteins
    Publication number: 20080207673
    Abstract: A method for treating diseases selected among cancer, coronary disease, inflammatory disease and macular disease by chelation therapy is disclosed.
    Type: Application
    Filed: May 4, 2006
    Publication date: August 28, 2008
    Inventor: Michel Xilinas
  • Use of phanquinone for the treatment or prevention of memory impairment
    Patent number: 7030136
    Abstract: The use of phanquinone (4,7-phenanthroline-5,6-dione) for the treatment or prevention of memory impairment is suggested. Also a method for improving the learning or memory of a normal subject is suggested, said method comprising the administering of phanquinone, optionally together with one or more pharmaceutically acceptable carrier(s).
    Type: Grant
    Filed: March 15, 2002
    Date of Patent: April 18, 2006
    Assignee: Prana Biotechnology Limited
    Inventors: Michel Xilinas, Panayotis Nikolas Gerolymatos
  • Use of phanquinone for the treatment of Alzheimer's disease
    Publication number: 20050003018
    Abstract: The use of phanquinone for the manufacture of a pharmaceutical composition for the prevention or the treatment of Alzheimer's disease is disclosed. Also methods of treatment or prevention of Alzheimer's disease are disclosed.
    Type: Application
    Filed: November 18, 2003
    Publication date: January 6, 2005
    Inventors: Michel Xilinas, Panayotis Gerolymatos
  • Use of phanquinone for the treatment of alzheimer's disease
    Patent number: 6670369
    Abstract: The use of phanquinone for the manufacture of a pharmaceutical composition for the prevention or the treatment of Alzheimer's disease is disclosed. Also methods of treatment or prevention of Alzheimer's disease are disclosed.
    Type: Grant
    Filed: October 19, 2000
    Date of Patent: December 30, 2003
    Assignee: P.N. Gerolymatos S.A.
    Inventors: Michel Xilinas, Panayotis Nikolas Gerolymatos
  • Use of phanquinone for the treatment or prevention of memory impairment
    Publication number: 20030055078
    Abstract: The use of phanquinone (4,7-phenanthroline-5,6-dione) for the treatment or prevention of memory impairment is suggested. Also a method for improving the learning or memory of a normal subject is suggested, said method comprising the administering of phanquinone, optionally together with one or more pharmaceutically acceptable carrier(s).
    Type: Application
    Filed: March 15, 2002
    Publication date: March 20, 2003
    Applicant: P. N. Gerolymatos S.A.
    Inventors: Michel Xilinas, Panayotis Nikolas Gerolymatos